Healthcare provider profile · identity verified

Dylan Estes, M.D.

Family Practice · VERGENNES, VT · NPI 1003278144

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	241	90
Rosuvastatin Calcium	Rosuvastatin Calcium	197	63
Lisinopril	Lisinopril	194	58
Oxycodone Hcl	Oxycodone Hcl	179	21
Levothyroxine Sodium	Levothyroxine Sodium	171	46
Amlodipine Besylate	Amlodipine Besylate	168	60
Gabapentin	Gabapentin	137	40
Eliquis	Apixaban	126	29
Metoprolol Succinate	Metoprolol Succinate	125	39
Losartan Potassium	Losartan Potassium	123	41
Omeprazole	Omeprazole	109	46
Metformin Hcl Er	Metformin Hcl	94	32
Clonazepam	Clonazepam	90	13
Albuterol Sulfate Hfa	Albuterol Sulfate	89	30
Jardiance	Empagliflozin	89	23
Hydrochlorothiazide	Hydrochlorothiazide	82	29
Simvastatin	Simvastatin	81	21
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	77	suppressed
Furosemide	Furosemide	77	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	69	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	68	23
Metformin Hcl	Metformin Hcl	67	23
Prednisone	Prednisone	67	50
Trulicity	Dulaglutide	61	12
Duloxetine Hcl	Duloxetine Hcl	60	27
Pantoprazole Sodium	Pantoprazole Sodium	59	25
Lorazepam	Lorazepam	56	21
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	55	suppressed
Ventolin Hfa	Albuterol Sulfate	52	11
Sertraline Hcl	Sertraline Hcl	45	19
Famotidine	Famotidine	44	20
Celecoxib	Celecoxib	43	19
Metoprolol Tartrate	Metoprolol Tartrate	41	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	39	suppressed
Carvedilol	Carvedilol	37	suppressed
Cefdinir	Cefdinir	37	32
Fluoxetine Hcl	Fluoxetine Hcl	37	14
Tramadol Hcl	Tramadol Hcl	37	15
Alprazolam	Alprazolam	35	11
Prochlorperazine Maleate	Prochlorperazine Maleate	33	suppressed
Breo Ellipta	Fluticasone/Vilanterol	32	suppressed
Diazepam	Diazepam	32	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	suppressed
Meloxicam	Meloxicam	30	16
Montelukast Sodium	Montelukast Sodium	30	13
Pregabalin	Pregabalin	30	11
Mirtazapine	Mirtazapine	29	suppressed
Spiriva Respimat	Tiotropium Bromide	29	suppressed
Trazodone Hcl	Trazodone Hcl	29	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	27	suppressed
Fluticasone Propionate	Fluticasone Propionate	27	suppressed
Irbesartan	Irbesartan	27	suppressed
Potassium Chloride	Potassium Chloride	27	11
Farxiga	Dapagliflozin Propanediol	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Pravastatin Sodium	Pravastatin Sodium	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	11
Vyvanse	Lisdexamfetamine Dimesylate	24	suppressed
Allopurinol	Allopurinol	23	suppressed
Doxepin Hcl	Doxepin Hcl	23	suppressed
Mounjaro	Tirzepatide	23	suppressed
Arnuity Ellipta	Fluticasone Furoate	22	suppressed
Azithromycin	Azithromycin	22	21
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Glipizide	Glipizide	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Methadone Hcl	Methadone Hcl	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	16
Prazosin Hcl	Prazosin Hcl	20	suppressed
Rybelsus	Semaglutide	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	12
Atenolol	Atenolol	19	suppressed
Nabumetone	Nabumetone	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	13
Temazepam	Temazepam	19	suppressed
Torsemide	Torsemide	19	suppressed
Citalopram Hbr	Citalopram Hydrobromide	18	suppressed
Clobetasol Propionate	Clobetasol Propionate	18	15
Glipizide Er	Glipizide	18	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Topiramate	Topiramate	18	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Fluconazole	Fluconazole	17	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Alendronate Sodium	Alendronate Sodium	16	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	16	suppressed
Testosterone	Testosterone	16	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	16	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Klor-Con	Potassium Chloride	15	suppressed
Loperamide	Loperamide Hcl	15	suppressed
Ozempic	Semaglutide	15	suppressed
Finasteride	Finasteride	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Incruse Ellipta	Umeclidinium Bromide	14	suppressed
Primidone	Primidone	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Varenicline Tartrate	Varenicline Tartrate	14	suppressed
Linzess	Linaclotide	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Betamethasone Valerate	Betamethasone Valerate	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Clopidogrel	Clopidogrel Bisulfate	12	suppressed
Colchicine	Colchicine	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Gemtesa	Vibegron	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Frovatriptan Succinate	Frovatriptan Succinate	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Nystatin	Nystatin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error